Photo: Depositphotos
Sep 5, 2025, 11:43
Conquering Underfunded and Rare Cancers Through Research – Conquer Cancer, the ASCO Foundation
Conquer Cancer, the ASCO Foundation shared a post on LinkedIn:
“Soft tissue sarcoma is a rare cancer that is genetically diverse, making it hard to find a reliable, one-size-fits-all indicator for recurrence. Conquer Cancer-funded researcher Dr. Abdulazeez Salawu is exploring circulating tumor DNA (ctDNA) to change that.
In his study, ctDNA was detectable in about 80% of patients at diagnosis, and the levels dropped to zero after surgery in most patients. Then, in nearly all patients, it reappeared weeks before a recurrence showed up on scans.
What’s next? Read more about Dr. Salawu’s rare cancer research.”
More posts featuring Conquer Cancer, the ASCO Foundation on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 5, 2025, 11:17
Sep 5, 2025, 10:43